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Choledocholithiasis: repetitive thick-slab
single-shot projection magnetic resonance
cholangiopancreaticography versus endoscopic
ultrasonography
Abstract This prospective study
compares repetitive thick-slab single-
shot projection magnetic resonance
cholangiopancreatography (MRCP)
with endoscopic ultrasonography
(EUS) for the detection of chole-
docholithiasis. Fifty-seven consecu-
tive patients (36 women, mean age 61)
referred for suspected choledocho-
lithiasis underwent MRCP, followed
by EUS. Each procedure was per-
formed by different operators blinded
to the results of the other investiga-
tion. MR technique included a turbo
spin-echo T2-weighted axial sequence
with selective fat saturation (SPIR/
TSE, TE=70 ms, TR=1,600 ms), fol-
lowed by coronal dynamic MRCP.
The same thick-slab slice was se-
quentially acquired 12 times as breath-
hold single-shot projection imaging
(SSh, TE=900 ms, TE=8,000 ms)
centred on the common bile duct
(CBD). Two experienced radiologists
independently and blindly evaluated
MR images for the detection of CBD
stones. Their inter-observer agreement
kappa was determined. Secondly, the
two observers read MR images in
consensus again. CBD stones were
demonstrated in 18 out of 57 patients
(31.6 %) and confirmed by endo-
scopic retrograde cholangiography
(ERCP, n=17) or intraoperative chol-
angiography (n=1). Clinical follow-up
served as the “gold standard” in
patients with negative results without
following invasive procedure (n=28).
Sensitivity, specificity, accuracy, pos-
itive and negative predictive value for
MRCP resulting from consensus
reading were 94.9%, 94.4%, 94.7%,
97.4% and 89.5%, respectively. Cor-
responding values of EUS were
97.4%, 94.4%, 96.5%, 97.4% and
94.4%. Inter-observer agreement
kappa was 0.81. Repetitive thick-slab
single-shot projection MRCP is an
accurate non-invasive imaging mo-
dality for suspected choledocholithia-
sis and should be increasingly used to
select those patients who require a
subsequent therapeutic procedure,
namely ERCP.
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Introduction
Choledocholithiasis occurs in 15–20% of patients with gall
bladder stones. Recurrent or persistent common bile duct
(CBD) stones are detected in 1–5% of patients after
cholecystectomy performed for calculi [1].
Endoscopic retrograde cholangiopancreaticography
(ERCP) continues to be considered as the standard of
reference for the detection of bile duct stones with the
possibility of simultaneous treatment. Nevertheless, ERCP
remains an invasive investigation and it is greatly operator
dependent. Associated complications, such as secondary
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pancreatitis, occur in 1–5% of cases [2–4]. Unnecessary,
purely diagnostic ERCP should therefore be avoided [3].
Many authors consider endoscopic ultrasonography
(EUS) as the most reliable pretherapeutic diagnostic tool
for choledocholithiasis, superior to magnetic resonance
cholangiopancreaticography (MRCP) and as accurate as
ERCP [5–9]. EUS is less invasive than ERCP, but, similar
to ERCP, the operator must be skilled and experienced.
Therefore, EUS is not readily available and diagnostic
results are highly operator-dependent [5, 7, 10, 11]. The
overall diagnostic value of EUS for choledocholithiasis has
been reported as a sensitivity of 80–100%, specificity of
88–100% and diagnostic accuracy of 95–98% [5, 6, 8–14].
MRCP has nowadays become a commonly used and easily
reproductive imaging modality. The acquisition of cholan-
giographic sequences can be performed on most middle- or
high-field MR scanners without special training or intra-
venous injection of contrast medium, thus rendering
MRCP a completely non-invasive technique that is little
influenced by the operator. The overall diagnostic value of
MRCP has been proven to be similar to that of ERCP [15]
and EUS for the detection of choledocholithiasis, provided
that CBD dilatation was associated in the majority of
included patients. The sensitivity varies between 80 and
100%, specificity between 85 and 100%, and a diagnostic
accuracy of 94–97% [6, 9, 10, 12, 13, 16–25].
However, if one takes into account only non-obstructive
CBD stones, MRCP is less sensitive. Statistical results for
this subgroup are also quite variable in the literature [9, 10,
18, 23]. This variability reflects differences in equipment,
the chosen MR technique and the experience of the
radiologists in image interpretation. Only the repetition of
thick-slab single-shot projection MRCP enables the visu-
alisation of the entire length of the CBD, which seems
mandatory for the reliable detection or exclusion of
choledocholithiasis.
Diagnostic results of EUS have been shown to be
independent of stone size or CBD dilatation [5]. Our
objective was, therefore, the prospective and direct
comparison of MRCP with EUS for the detection of
choledocholithiasis, relying on dynamic and sequential
thick-slab MR imaging (MRI) in order to visualise the
entire length of the CBD, in particular the sphincter
complex.
Patients and methods
Patients
From June 2003 through October 2004, 61 consecutive
adult patients with suspected choledocholithiasis were
considered to be included in this monocentric and
prospective evaluation comparing MRI versus EUS,
performed within a delay of 5 days. From the initial 61
patients we had to exclude two with biliodigestive
anastomosis (choledochojejunostomy, Billroth II), render-
ing EUS and ERCP impossible. Two other patients were
also excluded because of inadequate clinical follow-up.
Our final study population was composed of 57 patients
[36 women, mean age 61 years (±17.3), range=27–
92 years], among them 15 with a history of previous
cholecystectomy for calculi. Their clinical data are
resumed in Table 1.
Permission of the institutional ethical committee had
been obtained for this study, as well as informed oral
consent from the patients.
Technique of MRI
MRI was performed with a 1-Tesla magnet (Intera, Philips
Medical Systems, Best, The Netherlands) using a torso
phased-array receiving coil placed around the upper
abdomen. Patients were examined in the supine position
without any previous preparation, in particular no premed-
ication and neither was an oral contrast medium for
suppression of possible hyperintense gastric or duodenal
content administered [26].
A survey MR examination was followed by a turbo spin-
echo T2-weighted axial MR sequence with selective fat
saturation and respiratory compensation, centred on the
hepatobiliary region (SPIR/TSE) using the following
parameters: repetition time (TR) 1,600 m, echo time (TE)
70 ms, turbo factor 24, number of excitations (NEX) 2, slice
thickness 7 mm, matrix size 256×256 and field of view
(FOV) 435×435 mm. Twenty-five images were obtained
within about 38 s (factor SENSE 1). Saturation bands were
prescribed above and below the region or interest. Axial
images served as guide for choosing the angle of coronal
sections to be obtained at MR cholangiography.
Table 1 Clinical data of the study population
Clinical data Number
of patients
Pain situated in the upper right abdominal quadrant
or epigastric region and fever or jaundice with
associated increase of serum alkaline phosphatase
(normal 39–105 IU/l), serum gamma-glutamyl
transpeptidase (normal 5–36 IU/l) or total bilirubin
(normal 3–22 IU/l) possibly in combination with an
inflammatory syndrome (C-reactive protein >5 IU)
29
Acute pancreatitis of suspected biliary origin 21
Biological cholestasis with acute fever or jaundice 5
Acute upper abdominal pain and a clinical history
suggestive of biliary stones disease, such is known
cholecystolithiasis or acutely dilated CBD seen on
abdominal US or CT after cholecystectomy
2
Total study population 57
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MRCP included a breath-hold, turbo spin-echo sequence
(single shot) using a TR 8,000 ms, TE 900 ms, turbo factor
205, NEX 1 and a matrix size 256×205 reconstructed in
512×512 pixels for a FOV of 250×340 mm. Single shot
repetitive projection imaging comprised 12 dynamic slices
of 40-mm thickness, in the right anterior oblique coronal
plane and centred on the CBD, especially on the Vaterian
sphincter complex. Each section was acquired within a
single breath-hold of 2 s. Saturation bands over patient’s
left and right flank were used.
Film reading of MR images was done by two board-
certified radiologists with extensive practical experience in
hepatobiliary MRI. They were both blinded to the clinical
probability of choledocholithiasis as well as to the final
outcome. These two radiologists read the same images
again in consensus, still without any clinical information.
MRI was considered normal whenever the maximal
diameter of the CBD at the level of the hepatic hilus
measured <8 mm, respectively <11 mm in patients older
than 70 years or after cholecystectomy. Furthermore, the
entire course of the CBD, including the sphincter complex,
had to be clearly visible and characterised by a homoge-
neous hypersignal on either of the two T2-weighted MR
sequences. The two radiologists also evaluated in con-
sensus the number of repetitions necessary to visualise the
lumen of the sphincter complex for the first time, and how
often it could be seen in a relaxed state during the 12
repetitive MRCP sequences performed.
MRI was considered positive whenever a round, oval or
multifaceted area of signal void was seen within the T2
hyperintense lumen of the CBD. It must be detected on
either of the two different MR sequences (axial or coronal
oblique plane) performed; its size was exactly recorded.
Whenever several CBD stones were depicted in the same
patient, the largest one of them was statistically taken into
account.
In case of biliary sludge, seen as hypointense sediment
accumulating within the distal CBD, MRI was also
considered positive.
Technique of EUS
In all patients MRI preceded EUS, which had to follow
within 5 days.
Each EUS was performed and interpreted by a staff
gastroenterologist known for broad experience in endoso-
nography, using the system PENTAX EG-3630UR with a
radial technology ultrasound probe functioning at 5–
10 Mhz. It was connected to an HITACHI Alpha Harmonic
ultrasound machine of the newest generation (2004).
Patients were investigated under general anaesthesia
(introduced by propofol) in the left lateral decubitus
position after fasting for at least 8 h. After duodenal
intubation, the transducer was advanced to the third part of
duodenum. The progressive withdrawal of the echoendo-
scope towards the duodenal bulb allowed the visualisation
of the Vaterian sphincter complex and the distal CBD first,
followed by the proximal CBD, the hepatic and intrahe-
patic bile ducts. The examination took about 15 min.
As to the normal size of the CBD, the same criteria as
described above for MRI were applied.
CBD stones were diagnosed with EUS whenever a
hyperechoic focus with or without posterior acoustic
shadowing was detected within the lumen of the CBD [7].
Proof of disease
MRI and EUS were performed by different operators
blinded to the result of the other method used. In case of
negative EUS, the corresponding MRCP result was
immediately communicated as soon as EUS was finished,
while the patient was being kept on the table of the
endoscopy unit, still under general anaesthesia. If any or
both imaging modalities detected a CBD stone or any
unexplained common bile duct dilatation, immediate
ERCP or cholangiography during cholecystectomy was
performed and considered as the “gold standard”.
In case of both negative EUS and MRCP, and no
following invasive procedure, the clinical follow-up served
as the gold standard.
Statistical analysis
Image quality was assessed for each of the two MR
sequences and graded according to the depiction of the
intra-and extrahepatic bile ducts, and the papilla. We used
the scores 1 (excellent=visualisation of all these three
anatomical structures), 2 (good=identification of two out of
three anatomical structures) and 3 (moderate=detection of
one out of three anatomical structures).
Using the above-defined gold standard, sensitivity,
specificity, accuracy, positive (PPV) and negative pre-
dictive value (NPV) of MCRP and EUS for choledocho-
lithiasis were calculated (95% confidence interval,
P<0.05), whereby MRCP results resulted from radiolo-
gists’ consensus reading.
Inter-observer agreement concerning the detection of
CBD stones was determined between the two radiologists,
according to the common kappa rating defined by Fleiss
[27]: kappa <0.4=poor, 0.4–0.75=good, and >0.75=ex-
cellent agreement.
Presence of CBD dilatation seen on MRI and EUS was
compared (kappa). Linear regression was applied for
correlating the degree of CBD dilatation and correlating
the stone size detected by MRI and EUS using the
Pearson’s correlation coefficient (P<0.05).
Altogether, the chi-square statistic and Fisher exact test
were used to compare categorical variables, and the
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Student’s t-test for evaluation of continuous variables,
when appropriate.
Results
The mean interval time between MRI and EUS was
1.9 days (range 0–5 days).
EUS was successfully performed in each of the 57
patients without any complication.
Altogether, MRI could be interpreted in all patients. The
technical quality of the axial T2-weighted sequences was
graded excellent in 40 patients, good in 16 and moderate in
one patient. Dynamic MRCP images were considered
excellent in 26 patients, good in 29 and moderate in two
patients.
Common bile duct stones were detected in 18 out of 57
patients (31.6%) (Figs. 1, 2, 3), confirmed by ERCP in 17
patients and by intraoperative cholangiography in one
patient. The delay between EUS and ERCP/intraoperative
cholangiography was 4.1 days at an average (range 0–
9 days).
The mean clinical follow-up of the 28 patients with
negative result for both techniques, EUS and MRCP, and
without following invasive procedure was 123 days (range
17 days to 10 months).
Sensitivity, specificity, accuracy, PPV and NPV of
MRCP and EUS for the detection of CBD stones are
described in Table 2.
MRCP was once false-negative and twice false-positive.
EUS showed one false-negative and one false-positive
result. One false-positive result of MRCP and EUS
occurred in the same patient. Both techniques diagnosed
a prepapillary stone millimetric in size. EUS was not
followed by ERCP, but intraoperative cholangiography
was performed during cholecystectomy 5 days later, which
was negative. None of the 12 dynamic coronal MR
acquisitions could hereby clearly visualise the sphincter
complex in a relaxed state.
In the second false-positive result the analysis of the
sphincter complex on MRCP was hampered by a periam-
pullary diverticula of 4 cm.
MRCP yielded one false-negative result concerning a
patient with a normal size of intra-and extrahepatic bile
ducts. The CBD measured 6 mm on MRCP, but the
sphincter complex was not clearly visible (Fig. 4a). EUS
correctly revealed two small distal stones measuring 5 mm
each, also without any associated luminal dilatation
(Fig. 4b).
Fig. 1 A 30-year-old woman with biological cholestasis and acute
pain of the right hypochondrium. Prior abdominal sonography had
already detected several small gallbladder stones, but no relevant
bile duct dilatation. Coronal oblique T2-weighted thick-slab single-
shot turbo spin-echo MRCP sequence confirms microlithiasis of the
gall bladder (not well demonstrated on this image) and shows two
signal voids measuring 2 mm each (arrows) situated in the distal
portion of CBD causing slight dilatation of the intra-and extrahe-
patic bile ducts. EUS performed 24 h later confirmed these
microlithiasis, as well as following ERCP with calculi extraction
and sphincterotomy
Fig. 2 A 25-year-old man with acute epigastric pain, known for
chronic calculous cholecystitis. Coronal oblique T2-weighted thick-
slab single-shot turbo spin-echo MRCP sequence reveals numerous
macrolithiasis obstructing the whole CBD (arrows) with intrahepatic
bile duct dilatation, later confirmed by EUS and ERCP. Note also
the multiple calculi situated in the long cystic duct (arrowhead)
causing obstruction of the gall bladder which is sclerosed,
contracted and atrophied, therefore not visualised on this image
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EUS was false-negative in one patient with acute
pancreatitis and associated cholangitis. MRCP showed at
least three distal CBD stones without associated CBD
dilatation (Fig. 5). Immediate ERCP including sphincter-
otomy confirmed the MR result.
Inter-observer agreement between the two radiologists
for the detection of CBD stone disease was 0.81, therefore
excellent according to the ratings of Fleiss [31]. Disagree-
ment between the two readers occurred in five cases,
among them two patients with CBD stones measuring 2
and 4 mm in diameter, respectively; therefore non-
obstructive (one of them shown in Fig. 5). Both
radiologists agreed on the correct diagnosis of 15 patients
with choledocholithiasis. They also agreed on the single
false-negative result of MRCP (Fig. 4a) and on one of the
two false-positive results of MRCP, in which image
analysis was difficult because of a periampullary duodenal
diverticula. Concerning the second false-positive result of
MRCP, there was disagreement since one of the two
radiologists’ results had been true negative before
consensus reading.
Finally, there were two negative MRI examinations in
which one of the two observers made a false-positive
diagnosis, among them a 92-year-old and an unco-opera-
tive patient presenting with acute pancreatitis of suspected
biliary origin. MRCP was technically suboptimal because
of many movement artifacts.
In seven out of 18 patients (38.9%) with choledocho-
lithiasis, the CBD was of normal size on MRCP, among
them four cases with very small calculi measuring 2 mm in
diameter (n=4).
Dilated CBD seen on MRI agreed well with the presence
of dilatation diagnosed by EUS (κ=0.66). Even the degree
of CBD dilatation showed a very significant and positive
correlation between both imaging modalities (Pearson’s
correlation coefficient, r=0.81, P<0.0001).
Taking into account the largest diameter in case of
several stones, the stone size measured by EUS and MRI
also significantly and positively correlated with each other
(Pearson’s regression coefficient, r=0.66, P<0.0015).
Stone size varied between 2 and 8 mm on both imaging
modalities. The average stone size was 4.9 mm on MRCP
and 5.5 mm on EUS.
On dynamic MRCP, the Vaterian sphincter complex was
visualised in 26% of cases at the first repetition (n=15), in
72% (n=35) at least once during the 12 repetitions, and in
12% (n=7) not at all. The average visualisation of the
sphincter was 3.44 times for the given 12 repetitive images.
Discussion
There is no international consensus about the exact role of
imaging techniques in the diagnosis and management of
choledocholithiasis [21, 28]. In patients with clinical
symptoms strongly suggesting choledocholithiasis, such
as typical abdominal pain and clearly dilated CBD seen on
Table 2 Statistical results of MRCP and EUS for the detection of
choledocholithiasis resulting from our study and in comparison with
the previous publications (Sens sensitivity, Spe specificity, Acc
accuracy, PPV positive predictive value, NPV negative predictive
value. All these figures are given in percentage)
Reference Patients included
(with CBD stones)
MRCP EUS
Sens Spe Acc PPV NPV Sens Spe Acc PPV NPV
6 32(11) 100 72.7 82.2 62.5 100 100 95.4 96.9 90.9 100
13 50(9) 91 94 92 97 84 97 88 94 94 94
9 30(5) 40 96 86.7 66 88 80 95 93.3 80 96
12 47(16) 87.5 96.6 93.6 93.3 93.3 93.8 96.6 95.7 93.8 96.5
10 28(24) 88 75 86 95 50 100 50 93 92 100
Our study 57(18) 94.8 94.4 94.7 97.4 89.5 97.4 94.4 96.5 97.4 94.4
Fig. 3 A 67-year-old woman with acute onset of fever, jaundice and
diffuse abdominal pain. Coronal oblique T2-weighted thick-slab
(40 mm) single-shot turbo spin-echo MRCP sequence shows a great
amount of biliary sludge accumulating in the lower CBD (arrow)
with consecutive dilatation (star), also extending to the intrahepatic
bile ducts. These findings were confirmed by EUS and ERCP
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transabdominal US associated with jaundice and signifi-
cantly increased serum bilirubin level, therapeutic ERCP is
often immediately performed. The typical indication for
EUS as well as MRCP is the search of choledocholithiasis
in patients with a low and intermediate probability of stone
disease in order to avoid purely diagnostic ERCP [12, 14].
Hence, both techniques become competitive procedures,
directly compared by this study relying on dynamic MRI of
the extrahepatic bile duct.
EUS has been shown to be of particular advantage for
very small stones or sludge even in the non-dilated CBD
[14]. According to Scheiman et al. [9] and Buscarini and
Buscarini [7], EUS is the most cost-effective initial
imaging modality for patients with extrahepatic biliary
disease. However, EUS remains a semi-invasive technique,
necessitating neuroleptanesthesia, and in more complicated
cases even complete anesthesia. An important advantage of
EUS over MRCP is the possibility to proceed immediately
to ERCP in case of a positive result, the patient remaining
on the table still under anaesthesia. Treatment can therefore
be performed during the same session, while ERCP has to
be organised in a second step after a positive result of
MRCP. However, the latter remains completely non-
invasive, and therefore better tolerated than endoscopic
procedures by the majority of patients [29].
Previous studies focusing on MRCP and choledocho-
lithiasis [16, 20] have revealed two diagnostic challenges in
particular. The first is to detect small stones, measuring less
than 6 mm [10, 25, 30], which are not associated with CBD
dilatation [18]. The second is to detect prepapillary stones,
which may be impacted in the distal CBD. The percentage
of small, therefore non-obstructive, calculi is generally
under-estimated, representing 38.9% (n=7) of patients of
our study population with proven choledocholithiasis.
Fig. 4a, b A 91-year-old man presenting in emergency with the
clinical picture of cholangitis. a Coronal oblique T2-weighted thick-
slab single-shot turbo spin-echo MRCP sequence is not of excellent
technical quality because of patient’s advanced age associated with
minor compliance. MR result is false-negative since it does not
reveal any signal void neither luminal dilatation of CBD (arrow).
Note the anatomical variant of pancreas divisum (arrowhead).
b EUS performed the same day reveals two small non-obstructive
calculi of the distal CBDmeasuring 5 mm each (arrows), extracted by
following ERCP
Fig. 5 An 82-year-old woman, known for deafness and senile
dementia, with acute pancreatitis of suspected biliary origin and
associated cholangitis. Coronal oblique T2-weighted thick-slab
single-shot turbo spin-echo MRCP sequence reveals at least three
lacunar images (arrows) corresponding to three calculi of the lower
portion of CBD. Neither extra-nor intrahepatic bile duct dilatation is
seen on MRCP. Note associated gall bladder stone (arrowhead) and
the nice visualisation of the sphincter complex at a relaxed state
(star). EUS, performed the same day as MRI, did not reveal any of
the CBD stones detected by MRI. These, however, were confirmed
by immediately following ERCP
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According to Becker et al. [16], tiny calculi, as small as
2 mm in diameter, without secondary CBD dilatation are
best displayed on the axial source images because they are
perpendicular to the axis of the CBD. They may be
obscured by surrounding hyperintense bile on the MIP or
single-shot thick-slice coronal sequence.
The second diagnostic challenge, the detection of
prepapillary stones, depends on the individual MRCP
technique used. So far, there has not been any published
consensus about the optimal MRCP technique for the
investigation of choledocholithiasis [15, 28]. In order to
eliminate hyperintense gastric and duodenal content
possibly overlapping the bile ducts, the administration of
oral contrast and/or patient fasting has been recommended
[12, 16, 22, 31]. However, in our study we did not do such
patient preparation. Instead, we relied on the presence of a
sufficient amount of fluid within the duodenal lumen
allowing for the exact localization of the papilla of Vater
[26].
Most authors first perform axial slices of a fast or turbo
spin-echo T2-weighted MR sequence, followed by project-
ing imaging, which is heavily T2-weighted single-shot fast
or turbo spin echo sequences in the coronal oblique plane.
The latter are best performed as thick slabs of 20- to 50-mm
thickness [6, 12, 13, 15–17, 31]. To our knowledge, the use
of dynamic or repetitive thick-slab MR sequences in this
regard has not yet been reported.
Obviously, for reliable detection or exclusion of any
CBD stone visualisation of the entire length of the lumen is
mandatory. The distal part of the CBD, including the
Vaterian sphincter complex, is the most difficult anatomical
structure to demonstrate by MRCP, because of its periodic
contractile activity (i.e. 3–4 contractions/min per 4–5 s)
[32] (Fig. 6), and due to the small size of the
intrasphincteric portion of the duct [30]. Therefore, in at
least 15–20% of MRCP examinations the luminal delinea-
tion is not achieved [26]. Since MRI is performed in the
physiologically non-distended state of the biliary system,
its incomplete demonstration at MRCP does not necessar-
ily indicate disease [15]. However, it can simulate or
dissimulate CBD stones. False-negative readings of MRCP
can rarely occur, because small or impacted calculi at the
distal CBD or ampulla are very difficult, or even
impossible to detect, whenever the sphincter is contracted
[16, 22, 26]. False-positive readings of MRPC are more
frequent and mostly due to a forcefully contracted sphincter
with retrograde invagination appearing as so-called “pseu-
do-calculus sign”, [33] or after stone migration causing
edema of the papilla of Vater [16, 36]. In the study of
Sugiyama et al. [25], comparing MRCP with US and
ERCP, 22 (64.7%) out of 34 patients with choledocholithi-
asis presented with calculi situated in the distal part of the
CBD. This stresses the importance to visualise the entire
length of the CBD in order to achieve a confident
diagnosis.
According to Dalal et al. [35], the intravenous injection
of the sphincter-relaxing agent glucagon during MRCP is
able to improve the visualisation of the CBD and ampulla
of Vater. However, these authors did not use any control
group for their evaluation, in contrast to van Hoe et al. [26],
who could not prove any apparent effect on the visibility of
the most distal portion of the CBD secondary to
intravenously injected glucagon. The easiest and possibly
only way to reliably visualise the sphincter is, therefore, to
consecutively perform several repetitive MRCP sequences,
always centred on the sphincter complex during successive
episodes of breath-holding. The chosen section thickness
must be a compromise between spatial resolution, which
increases with thinner slices, and the chances of constant
visualisation of the sphincter complex, which increases
Fig. 6a, b A 93-year-old
woman known for gallbladder
stones (star), at present compli-
cated by biological cholestasis
(elevated bilirubin levels). a
Coronal oblique T2-weighted
thick-slab single-shot turbo spin-
echo MRCP sequence dem-
onstrates normal size (7 mm) of
the CBD, but the distal portion
of CBD cannot be analysed,
since the sphincter is contracted.
b Due to several repetitions of
the same coronal oblique T2-
weighted thick-slab (40 mm)
single-shot turbo spin-echo
MRCP sequence the whole
length of CBD becomes visible
and the sphincter complex is
nicely seen at a relaxed state
(arrow), therefore prepapillary
stone can reliably be excluded
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with slice thickness [26]. Furthermore, there is a large inter-
individual variability for the exact anatomic localization of
the papilla of Vater. The number of image repetitions
necessary to obtain an adequate visualisation of the
sphincter complex in a relaxed state therefore greatly
differs among the patients, as it did in our study.
Thanks to the 12 repetitions of the dynamic coronal 40-
mm thick-slab single-shot projection MRCP centred on the
sphincter complex, the entire CBD had become completely
visible in 72% (n=35) of our patients, while it was seen in
only 26% (n=15) during the first repetition, which means
an increase of 46% (n=20). This improved visualisation of
the distal CBD enabled us to confidently exclude the
presence of any calculus within the CBD, especially in
these 20 patients in whom the acquisition of one single
projection MRCP would have caused a false-positive result
because of sphincter contraction.
In seven patients of our study, the sphincter complex was
not visible at all, despite the 12 repetitions performed. We
therefore had to rely on axial sequences for the evaluation
of the distal CBD, still keeping in mind that MRCP
altogether remains suboptimal in diagnostic quality. In
these seven patients, the sphincter complex might have
been seen if we had acquired even more repetitive images.
Van Hoe et al. [26] described a high inter-indivual
variability in this regard, ranging from 2 to 18 slices,
even in the absence of sphincter dysfunction. However, our
choice to perform exactly 12 repetitions resulted from a
practical compromise: to get enough sequential slices
necessary to achieve a confident diagnosis and to respect a
length of MR examination time still well-accepted by our
patients.
To our knowledge, there have been five previous
publications directly comparing EUS and MRCP, among
them three [6, 10, 12] exclusively dealing with choledocho-
lithiasis [6, 9, 10, 12, 13] (Table 2). Similar to our study,
most of the diagnostic results of EUS are slightly better
than these of MRCP. However, the differences are mostly
not statistically significant. None of these authors used
dynamic MR sequences centred on the sphincter complex.
They all performed heavily T2-weighted single-shot pro-
jection MRCP in the coronal or coronal oblique plane,
mostly acquiring thick slices of 20 mm, with the exception
of Scheiman and co-workers, who used thin slices of 5 mm,
later reconstructed as MIP. The latter are considered of
suboptimal quality and less useful for detection of small
stones especially, when compared with thick slabs [17, 26,
34]. This partly explains the poor sensitivity of MRCP
reported by these authors [9]. The small size of stones (3–
6 mm, average size=4 mm) in this study may also play a
role. Statistical interpretation is also difficult because of the
low prevalence of choledocholithiasis and the small
number of patients (n=5) with a positive result [9].
MR image analysis of the five publications cited above
was exclusively done by one radiologist [6, 9] or by two in
consensus [12, 13], but none of them studied the
reproducibility of the MR results obtained by several and
independent readings. Our aim was to stress the objective
nature of image interpretation by calculating the inter-
observer agreement between two observers. The excellent
kappa value we obtained (κ=0.8) is consistent with the
results of previous studies in this regard, where MRCP was
mostly compared with ERCP [16, 18, 19, 22, 24].
Our good agreement (κ=0.66) between EUS and MRCP
concerning CBD dilatation has been confirmed by the
study of Aubé et al. [12], who obtained a kappa value
slightly superior than ours (κ=0.86). The highly significant
correlation of stone size between both modalities resulting
from our study agrees with the results of de Lédinghen et
al. [6]. Our five disconcordant readings were due to
suboptimal technique (movement artefacts), anatomic
variants (periampullary duodenal diverticula) and presence
of small, non-obstructive CBD stones.
Dynamic bile duct imaging has recently been described
by drip infusion cholangiography using multidetector CT
(MDCTCh) [36, 37]. Compared with MRCP, MDCTCh
showed slightly better diagnostic values in 15 patients with
choledocholithiasis (MRCP: sensitivity 80%, specificity
88%, MDCTCh: sensitivity 87%, specificity 96%). How-
ever, the technique of MRCP only consisted of MIP images
without any dynamic imaging, and the delay between
MDCTCh and MRCP was 2 weeks, therefore quite long
[36]. Finally, MDCTCh is an ionizing procedure and
necessitates parenteral contrast injection, which has some
limitations, such as serum bilirubin levels and adverse
reactions.
Our study shows several limitations. First, the median
time interval between MRCP, respectively EUS and ERCP
or intraoperative cholangiography was 4.1 days. This delay
may be responsible for the one false-positive result we met
with MRCP and EUS. Both diagnosed a prepapillary
millimetric-sized stone in one patient, while intraoperative
cholangiography performed 5 days later was normal.
Meanwhile, spontaneous migration may have occurred.
Our time interval lies, however, within the limits reported
in the literature, ranging between 5 h and 2 weeks [10, 12,
13, 21].
Secondly, we cannot exclude the possibility that one
patient of our study population presented a possible
sphincter dysfunction. In general, we consider 12 repetitive
images of MRCP as sufficient for the visualisation of the
sphincter complex at least once in a relaxed state.
Nevertheless, this failed in 12% (n=7) of our patients,
mostly due to inconstant breathing or reduced patient
collaboration because of the severity of the disease.
Another explanation may be the limited spatial and contrast
resolution of our hardware equipment, the 1-T magnet.
However, we think, that our study still reflects current
technical equipment present in radiological departments for
routine clinical settings worldwide.
Finally, our gold standard for choledocholithiasis was
ERCP, although its accuracy is not 100% [16, 22, 28].
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ERCP remains an operator-dependent technique. In the
hands of experienced biliary endoscopists, 94–100% of
CBD stones may be detected if the bile duct is successfully
opacified [38]. Very small stones, in particular, suspected
on EUS or MRCP, may have not been visualised or may
have migrated beforehand. This should be kept in mind for
any study dealing with ERCP and biliary calculi.
In conclusion, our prospective comparison of MRCP
and EUS for the detection of choledocholithiasis yielded
statistically similar diagnostic values for both techniques.
Therefore, as a completely non-invasive procedure, MRCP
should be preferred to select patients requiring therapeutic
ERCP. We stress the importance of repetitive thick-slab
MRCP sequences centred on the sphincter complex
achieving its visualisation in a relaxed state, in order to
overcome the well-known diagnostic drawbacks inherent
in the MRCP technique. Achieving thus a higher diagnostic
value than without dynamic MR imaging, we think that
sequential thick-slab MRCP acquiring the same coronal
slice at least 12 times should routinely be applied for the
detection of choledocholithiasis. A confident diagnosis
made on MRCP requires visualisation of the entire length
of the CBD.
In MRCP-negative patients and persistent clinical
concern for choledocholithiasis it seems appropriate to
proceed to EUS for the evaluation of microlithiasis, with
the possibility of therapeutic ERCP during the same
session.
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